KAITLIN CHAMPIE: Open Payments
NPI 1184460420 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $54 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $121 |
| Novo Nordisk Inc | 2 | $116 |
| PFIZER INC. | 4 | $63 |
| Amgen Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Hologic Sales and Service, LLC | 1 | $18 |
Products named: ZEPBOUND, Ozempic, NURTEC ODT, VRAYLAR, Veozah, KRYSTEXXA, ROTATEQ, APTIMA.
Industry payments across NV — which companies pay providers there.
